Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Immune Checkpoint Inhibitors × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Solid Cancers 2 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Skin Neoplasms 1 Sarcopenia 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoadjuvant Therapies 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1

Interventions

venetoclax 87 Azacitidine 69 Cytarabine 52 fludarabine 43 Specimen Handling 36 Biopsy 26 Daunorubicin 25 Cyclophosphamide 25 Decitabine 24 fludarabine phosphate 22 Injections 19 Granulocyte Colony-Stimulating Factor 18 Busulfan 17 Whole-Body Irradiation 16 Stem Cell Transplantation 15 Idarubicin 15 Mycophenolic Acid 14 Melphalan 14 Tacrolimus 13 CPX-351 13 gilteritinib 11 decitabine and cedazuridine drug combination 11 Filgrastim 11 enasidenib 9 ivosidenib 8 Mitoxantrone 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Gemtuzumab 8 Cladribine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡